Short Interest in Sonova Holding (OTCMKTS:SONVY) Increases By 219.5%

Sonova Holding (OTCMKTS:SONVY) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 36,769 shares, a growth of 219.5% from the December 31st total of 11,510 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 45,081 shares, the short-interest ratio is currently 0.8 days. Based on an average trading volume of 45,081 shares, the short-interest ratio is currently 0.8 days. Approximately 0.0% of the company’s shares are short sold.

Analysts Set New Price Targets

A number of research firms have recently issued reports on SONVY. Royal Bank Of Canada upgraded Sonova to a “moderate buy” rating in a research note on Tuesday, November 18th. Zacks Research lowered Sonova from a “hold” rating to a “strong sell” rating in a report on Tuesday, December 9th. BNP Paribas Exane started coverage on shares of Sonova in a research note on Monday, October 20th. They set an “underperform” rating on the stock. Finally, Rothschild Redb upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Sonova Price Performance

Shares of SONVY stock opened at $55.84 on Wednesday. The company’s 50 day moving average price is $51.94 and its two-hundred day moving average price is $54.78. Sonova has a 52 week low of $47.55 and a 52 week high of $71.50. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.91 and a current ratio of 1.24.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.